Regen BioPharma Inc (RGBP)

[Bridget21]

Post 90874 MrGainsKepper

FLASHBACK! Aug. 09, 2017 Is Regen BioPharma A Buyout Target? Probably now more than ever.

Buyout Target Potential (Bristol Myers-IMF Therapeutics $2.3B)
N2RF6 10X Less Toxic-Most Advanced in industry
VariousCancers, Lupus, Rare Blood & Auto Immune Disease Treatments
Bio Tech-Stem Cell Clinical Stage Company

We have said for sometime we believe $RGBP is a potential buyout target. A Long Play. Now just imagine and/or think, are you in position if or when this day comes?

Regen has had major breakthroughs and great results with their new drug HemaXellerate during "Human" clinical trials for the treatment of aPlastic Anemia, a rare blood disease. They have also during this process discovered a new, much larger market for HemaXellerate. $RGBP has discovered that HemaXellerate is effective in treating Bone Marrow Suppression, a very painful condition as a result of chemo therapy.

https://seekingalpha.com/instablog/32618395-small-cap-solutions-llc/5024702-is-regen-biopharma-buyout-target-potential-otcqb-rgbp